{
    "Trade/Device Name(s)": [
        "EliA Celikey IgA Immunoassay",
        "EliA Celikey IgA",
        "EliA Celiac Control"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K062787",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041174"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MVM"
    ],
    "Summary Letter Date": "December 29, 2006",
    "Summary Letter Received Date": "September 18, 2006",
    "Submission Date": "September 15, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Tissue transglutaminase autoantibodies immunological test system, Antigen and Control"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgA antibodies to tissue transglutaminase (tTG)",
        "IgG antibodies to tissue transglutaminase (tTG)",
        "IgA antibodies to gliadin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (EDTA, citrate)"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ImmunoCAP 100",
        "ImmunoCAP 250"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "Fluorescence Immunoassay"
    ],
    "Methodologies": [
        "Non-competitive solid phase EIA",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Calibrator",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for EliA Celikey IgA Immunoassay and EliA Celiac Control for semi-quantitative measurement of IgA antibodies to tissue transglutaminase in serum and plasma as aid in celiac disease diagnosis",
    "Indications for Use Summary": "EliA Celikey IgA Immunoassay is intended for semi-quantitative measurement of IgA antibodies to tissue transglutaminase in human serum and plasma as aid in diagnosis of celiac disease; EliA Celiac Control is intended for laboratory monitoring of in vitro measurement of antibodies to tissue transglutaminase using ImmunoCAP 100/250",
    "fda_folder": "Immunology"
}